Singapore biotech firm Hummingbird Bioscience secures $125m in Series C
Singapore-based clinical-stage biotech company Hummingbird Bioscience has raised $125 million in its Series C funding round led by Novo Holdings, ...
AsiaTechDaily – Asia's Leading Tech and Startup Media Platform
Singapore-based clinical-stage biotech company Hummingbird Bioscience has raised $125 million in its Series C funding round led by Novo Holdings, ...